rs145056421
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_003900.5(SQSTM1):c.457G>A(p.Val153Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000341 in 1,613,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003900.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SQSTM1 | NM_003900.5 | c.457G>A | p.Val153Ile | missense_variant | 3/8 | ENST00000389805.9 | |
SQSTM1 | NM_001142298.2 | c.205G>A | p.Val69Ile | missense_variant | 4/9 | ||
SQSTM1 | NM_001142299.2 | c.205G>A | p.Val69Ile | missense_variant | 4/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SQSTM1 | ENST00000389805.9 | c.457G>A | p.Val153Ile | missense_variant | 3/8 | 1 | NM_003900.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000276 AC: 42AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000291 AC: 73AN: 251200Hom.: 0 AF XY: 0.000294 AC XY: 40AN XY: 135882
GnomAD4 exome AF: 0.000348 AC: 508AN: 1461688Hom.: 0 Cov.: 31 AF XY: 0.000370 AC XY: 269AN XY: 727144
GnomAD4 genome ? AF: 0.000276 AC: 42AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74354
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 28, 2023 | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is higher than would generally be expected for pathogenic variants in this gene (http://gnomad.broadinstitute.org). Computational tools disagree on the variant's effect on normal protein function. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 13, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 13, 2022 | Reported in individuals with ALS and in unaffected controls (Fecto et al., 2011; Shimizu et al., 2013; van der Zee et al., 2014; Cady et al., 2015; Cuyvers et al., 2015; Morgan et al., 2017; Yilmaz et al., 2020); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26234378, 35240373, 28166811, 25796131, 32594029, 31859009, 34009082, 23812289, 24899140, 22084127, 27275741, 28430856, 25382069) - |
Paget disease of bone 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;C4085251:Paget disease of bone 2, early-onset Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jan 15, 2024 | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 153 of the SQSTM1 protein (p.Val153Ile). This variant is present in population databases (rs145056421, gnomAD 0.04%). This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 22084127, 23812289, 24899140, 25796131, 31859009). ClinVar contains an entry for this variant (Variation ID: 571746). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SQSTM1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | Jun 06, 2023 | This sequence change in SQSTM1 is predicted to replace valine with isoleucine at codon 153, p.(Val153Ile). The valine residue is weakly conserved (100 vertebrates, UCSC), and is located in the zinc finger domain. There is a small physicochemical difference between valine and isoleucine. The highest population minor allele frequency in the population database gnomAD v2.1 is 0.042% (54/128,964 alleles) in the European (non-Finnish) population. This variant has been reported in individuals with amyotrophic lateral sclerosis (PMID: 22084127, 23812289). Computational evidence predicts a benign effect for the missense substitution (REVEL = 0.161). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: BP4 - |
SQSTM1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 15, 2023 | The SQSTM1 c.457G>A variant is predicted to result in the amino acid substitution p.Val153Ile. This variant was reported in an individual with amyotrophic lateral sclerosis (ALS) who also carried an additional missense variant in SQSTM1 in trans (Shimizu et al. 2013. PubMed ID: 23812289) and has been observed in other patients with ALS (Table 1 in Yilmaz et al. 2019. PubMed ID: 31859009; Fecto et al. 2011. PubMed ID: 22084127). In another study, this variant was found in one patient with ALS, but also observed in three controls (Table 2, van der Zee et al. 2014. PubMed ID: 24899140). In a large ALS case-control study, the c.457G>A variant was reported in one healthy control but not in any individuals with ALS (Morgan et al. 2017. PubMed ID: 28430856). This variant has also been observed in an individual with glaucoma and and individual with Alzheimer disease, but was also observed in otherwise healthy controls in both studies (Scheetz et al. 2016. PubMed ID: 27275741; Table 1 Cuyvers et al. 2015. PubMed ID: 25796131). This variant is reported in 0.042% of alleles in individuals of European (Non-Finnish) descent in gnomAD, which is likely too common for a fully penetrant autosomal dominant variant. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at